RetCAD: Precision Eye Health Analysis with AI

Introducing RetCAD, ushering a brighter and clearer future. Leveraging advanced AI, it swiftly identifies eye concerns such as Age-related Macular Degeneration (AMD) and Diabetic Retinopathy (DR). RetCAD meticulously analyses fundus images, promptly flagging potential risks within a minute. This ensures patients receive timely care, facilitating swift intervention, prioritising patient well-being, and optimising the workflow for eye-care professionals. As a CE-certified tool, RetCAD’s outstanding performance aligns with that of human experts, reducing the workload on specialists and enhancing the standard of patient care. RetCAD guarantees accuracy while ensuring patient confidentiality and upholding data integrity through secure and efficient data transfer processes.

Delft Imaging believes that every man, woman
and child should benefit from advances in healthcare
– regardless of where they live.

About Delft Imaging

At Delft Imaging, we dream of a world where healthcare is a universal right, not a privilege. Through our reliable, cost-effective diagnostic imaging solutions and AI software, we’re driving global health transformations, aiming for a universally healthier future with each innovation.

Innovative Solutions

High-Quality Imaging and Safety

Full After-Service Support

Local Partnerships